HCWB News and Press, HCW Biologics Inc.

2024-05-16 11:17:19 ET More on HCW Biologics Seeking Alpha’s Quant Rating on HCW Biologics Historical earnings data for HCW Biologics Read the full article on Seeking Alpha For further details see: HCW Biologics GAAP EPS of -$0.14, revenue of $1.1M

MIRAMAR, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link be...

2024-04-01 16:37:35 ET More on HCW Biologics Seeking Alpha’s Quant Rating on HCW Biologics Historical earnings data for HCW Biologics Read the full article on Seeking Alpha For further details see: HCW Biologics GAAP EPS of -$0.15, revenue of $1.3M

MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link ...

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...

2023-11-14 09:30:02 ET More on HCW Biologics Seeking Alpha’s Quant Rating on HCW Biologics Historical earnings data for HCW Biologics Financial information for HCW Biologics For further details see: HCW Biologics GAAP EPS of -$0.14, revenue of $174...

MIRAMAR, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link b...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

2023-11-08 09:40:13 ET DENVER, Colo., Nov 8, 2023 ( www.247marketnews.com )- HCW Biologics Inc (NASDAQ: HCWB) stated that data from a preliminary human data readout from an ongoing Phase 1 clinical trial sponsored by the University of Minnesota to evaluate HCW9218, the lead drug candida...

Showed HCW9218 clinical safety and tumor response endpoints for 15 patients with heavily pretreated advanced solid tumors Results in ovarian cancer patients outpace other indications, with 66% stable disease MIRAMAR, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- HCW Biologics In...